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ong-term  home  cage  activity  scans  reveal  lowered  exploratory
ehaviour  in  symptomatic  female  Rett  mice
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 i g  h  l  i  g  h  t  s
Mecp2Stop mutant  female  mice  develop  Rett-like  symptoms  late  in  life  (>6 months).
Symptoms  include  anomalies  in  motor,  activity  and  anxiety  proﬁles  and  were  assessed  in  various  behavioural  tasks.
Deﬁcits  occurred  in ambulatory  activity  during  novelty  exploration  and habituation  to  a novel  environment.
Circadian  rhythms  and anxiety  were  not  affected,  but  food  intake  was  higher  and  global  activity  lower  in  mutant  mice.
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a  b  s  t  r  a  c  t
Numerous  experimental  models  have  been  developed  to reiterate  endophenotypes  of Rett  syndrome,
a  neurodevelopmental  disorder  with  a multitude  of  motor,  cognitive  and  vegetative  symptoms.  Here,
female  Mecp2Stop mice  [1]  were  characterised  at mild  symptomatic  conditions  in  tests  for anxiety  (open
ﬁeld,  elevated  plus  maze)  and  home  cage  observation  systems  for  food  intake,  locomotor  activity  and
circadian  rhythms.
Aged  8–9  months,  Mecp2Stop mice  presented  with  heightened  body  weight,  lower  overall  activity  in
the  open  ﬁeld,  but  no  anxiety  phenotype.  Although  home  cage  activity  scans  conducted  in  two  different
observation  systems,  PhenoMaster  and  PhenoTyper,  conﬁrmed  normal  circadian  activity,  they  revealed
severely compromised  habituation  to a  novel  environment  in all  parameters  registered  including  those
derived from  a non-linear  decay  model  such  as initial  exploration  maximum,  decay  half-life  of  activity
and  span,  as well  as  plateau.  Furthermore,  overall  activity  was signiﬁcantly  reduced  in nocturnal  periods
due to reductions  in  both  fast  ambulatory  movements,  but also  a slow  lingering.  In contrast,  light-period
activity  proﬁles  during  which  the  amount  of  sleep  was  highest  remained  normal  in  Mecp2Stop mice.
These  data  conﬁrm  the slow  and progressive  development  of Rett-like  symptoms  in female  Mecp2Stop
mice  resulting  in  a prominent  reduction  of overall  locomotor  activity,  while  circadian  rhythms  are main-
tained.  Alterations  in  the  time-course  of  habituation  may  indicate  deﬁciencies  in cognitive  processing.. IntroductionRett syndrome is a neurological disorder that primarily affects
emales and is characterised by apparently normal early devel-
pment up until 6–18 months of age, upon which a period of
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on-commercial use, distribution, and reproduction in any medium, provided the
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regression and the development of symptoms including loss of
acquired skills, deceleration of head growth, development of ataxia,
seizures, scoliosis, breathing anomalies and autistic behaviour is
observed [2].
The majority of cases of Rett syndrome result from mutations
in the gene encoding methyl-CpG-binding protein 2 (Mecp2)
on the X chromosome [3]. Several mouse models that lack or
express a truncated MeCP2 protein have been developed, and
successfully recapitulate many of the clinical symptoms associated
with Rett syndrome [4–6]. In keeping with the disease, mutant
mice have apparently normal early development followed by
the emergence of symptoms and progressive dysfunction such
as abnormal gait, hypoactivity, irregular breathing and tremors.
Male null mutants present with early onset of symptoms rapidly
reserved.
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rogressing in severity and a short life span of only 8–12
eeks [4,5]. By contrast, heterozygous females show a late-
nset phenotype at 4–12 months and, similar to human
atients, these symptoms stabilise so that mice experi-
nce a normal life span. Truncation of the Mecp2 allele
fter codon 308 (Mecp2308/Y) produces a less severe phe-
otype and mutant males survive until adulthood [6], but
ecp2308 heterozygous females have unbalanced patterns of
-chromosome inactivation predominantly expressing the wild-
ype allele leading to a high degree of variability in phenotypes
7,8].
Neuroanatomical studies of brain areas affected in Rett patients
eported a reduction in overall brain volume and atrophy in regions
ssociated with motor function including the caudate nucleus
9] and cerebellum [10,11]. Mecp2 null mice also display abnor-
alities in the cerebellum and motor cortex [12] and suggest
his to be a mechanism for behaviourally recorded reductions in
ocomotor activity in the open-ﬁeld [13–16]. However, it is con-
eivable that reduced ambulatory activity may  not be a direct
ndicator of locomotion, but instead reﬂects altered anxiety lev-
ls in response to the novel environment, and this would be
n agreement with previous studies providing compelling evi-
ence that Mecp2 deﬁcient mice have heightened levels of anxiety
6,13,17–23]. One possible strategy to monitor locomotor activ-
ty uncontaminated of novelty-dependent anxiety would be to
erform home cage activity scans in these mice. Such long-term
ontinuous recordings may  provide additional information on
ircadian rhythms, amounts of active locomotion relative to lin-
ering, speciﬁc patterns of cage exploration as well as feeding
nd/or drinking orientated behaviours [24]. It would further reveal
hether mouse phenotypes include Rett-typical abnormalities in
leep/wake cycle [25,26] or food intake patterns as a mechanism
nderlying the observed obesity in patients [27] and Mecp2 mutant
ice [4,5,16,18,19,28].
Despite Rett occurring predominantly in females, investiga-
ions using Mecp2 deﬁcient mouse models have concentrated on
ales with few exceptions [15,16,20,22]. Mecp2 null males develop
ost-natal symptoms early (within few weeks) so that recording
an take place in young adult subjects and behavioural endpoints
re readily met, with the additional beneﬁt of reduced costs. At
he same time, this precludes tracing the behavioural progres-
ion in longitudinal analyses as the severity of symptoms rapidly
rogresses. Consequently, extensive data are available for male
ecp2308/Y mice due to their mild phenotypes, but little is known
bout neurobehavioural anomalies of heterozygous female mice,
lthough females might more realistically mimic  the condition of
ett patients at the molecular level [22,29]. Since behavioural phen-
types of Rett models based on different Mecp2 mutations did not
verlap [30], an assessment of each individual model is neces-
ary.
Here, we investigated the anxiety- and motor-related phen-
types of female heterozygous Mecp2Stop mice by attempting
o capture symptoms in overall activity through scanning their
ehaviour in an open ﬁeld followed by ﬁne-grained investigations
f circadian/ultradian activity in different home-cage environ-
ents. The beneﬁt of using two home-cage observation systems is
hat in addition to assessing exploratory activity by way of different
racking parameters (infrared beams or overhead infrared camera)
ach system has distinctive recording features which complement
ne another and facilitate in the characterisation of the mice in
erms of exploration, circadian and feeding orientated behaviour.
he PhenoMaster (TSE Systems, Germany) permits direct measure-
ent of food and water intake and also facilitates the distinction
etween different types of ambulation. Whereas, the PhenoTyper
Noldus IT, The Netherlands) allows the tracking of behaviours
patrolling and feeding) based on user-deﬁned zones, as anesearch 250 (2013) 148– 156 149
indirect measure of feeding behaviour/food intake. We  reveal over-
all reductions in open ﬁeld exploration due to lower ambulatory
activity in Mecp2Stop mice not related to heightened anxiety levels
or endophenotypes affecting circadian rhythms.
2. Materials and methods
2.1. Subjects
Female mice in which the endogenous Mecp2 gene was silenced by insertion
of  a targeted lox stop cassette (Mecp2Stop) were crossed with males hemizygous
for the CreESR transgene [1]. For the purpose of this study only heterozygous
Mecp2Stop/+ females without the cre-ER transgene and wild-type (WT) littermates
were selected. Animals were bred on a C57BL6/J/CBA background. Fifty female
mice bred at a commercial vendor (Harlan, UK) and delivered to our facility aged
6  months were used and assigned to two  cohorts: Cohort 1: n = 30 (13 Mecp2Stop
and 17 WT)  were tested in open-ﬁeld and elevated plus maze; Cohort 2: n = 20
(10 Mecp2stop and 10 WT)  were scanned over 7 days in the PhenoTyper (Noldus IT,
Wageningen, The Netherlands) and then over a similar time course in the Pheno-
Master (TSE Systems, Bad Homburg, Germany) for circadian activity and food/water
intake. Mice were group housed with littermates (unless in the recording equip-
ment) and maintained on a 12 h light/dark cycle (lights on 7 am)  with free access
to  food and water. All procedures were performed in accordance with Home Ofﬁce
regulations.
2.2. Assessment of symptoms
Both body weight and symptom score of mice was recorded weekly; scores
for  individual symptoms associated with Mecp2 deﬁciency included mobility, gait,
hindlimb clasping, tremor, breathing and general condition. Each symptom scored
as  0 (absent/as wild-type); 1 (symptom present) or 2 (symptom severe) as previ-
ously described [1,31]. Testing in the open-ﬁeld, elevated plus maze and home-cages
commenced when the average severity symptom score of Mecp2Stop mice was 5/6.
At  this stage Mecp2Stop mice typically presented with a mild/moderate reduction
in  mobility, abnormal gait, hindlimb clasping and onset of tremors. However, the
general health and condition of the mice was comparable to that of WT.
2.3. Open-ﬁeld test
Explorative behaviour and emotionality was determined in an open ﬁeld. A
white square arena (50 cm × 50 cm) positioned in a dimly lit room (light intensity:
151  lux) with an overhead video camera connected to a PC based tracking software
(Ethovision 3.1, Noldus IT) was set up to continuously record activity of the animals.
The software monitored the actual movement based on a body-centred contrast
subtracted from background and calculated the following parameters: total dis-
tance moved; velocity; time spent in inner/outer zones equidistant from the centre
of  the arena.
All subjects were acclimatised to the room for 5 min, and then released in the
centre of the arena for a total exploration time of 10 min. They were returned to
their home cages, the arena cleaned with all purpose maceratable wipes, and the
next mouse was  introduced. Data were analysed using factorial analysis of variance
(ANOVA) with genotype (between-subject) and time (within-subject) as factors fol-
lowed by appropriate post hoc tests with Bonferroni adjustments. In all analyses,
the null hypothesis was  accepted for alpha smaller than 0.05.
2.4. Elevated plus maze
The elevated plus maze (EPM) was light grey in colour and comprised of two
open arms (35 cm × 5 cm) and two closed arms (35 cm × 5 cm × 15 cm; L × W × H)
which extended from a central platform (5 cm × 5 cm). Like arms were arranged
opposite to each other in the shape of a plus sign. The apparatus was  elevated 42 cm
above a table in a dimly illuminated room (light intensity: 142 lux). Prior to testing,
mice were transferred to the experimental room and acclimatised for 1 h. At the
beginning of a trial mice were individually placed onto the central platform facing an
open arm followed by 5 min  free exploration. Frequency of entries and time spent in
the  open/closed arms was  recorded online (Ethovision 3.1) and statistically assessed
using paired two-tailed t-tests. The maze was thoroughly cleaned using ethanol
between subjects.
2.5. Home cage activity scans
Two  variants of home-cage observation systems were utilised: (1) the Pheno-
Master/LabMaster; (2) the PhenoTyper. In both tests, animals were singly housed
and subjected to a 12 h light/dark cycle (lights on 7 am,  temperature 23 ± 2 ◦C, rel-
ative  humidity of 40–60%). They were placed into the cages containing sawdust
bedding at lunchtime and given 2 days of habituation before assessment of circa-
dian/ultradian activity over 3 continuous day–night cycles.
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Fig. 1. Symptom severity score, body weight and anxiety-related behaviour of Mecp2Stop mice. Means ± SEM. (A) Mecp2Stop mice presented with a progressively increasing
symptom score, which attained a mean of 5/6 in weeks 16–24 of testing. (B) Mecp2Stop mice also displayed a sustained increase in body weight compared to WT’s. Shaded
area  indicates period of behavioural assessment. (C) Ambulatory activity in the open ﬁeld during 10 min  of recording plotted in minute bins. Mecp2Stop mice presented with
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feduced locomotor activity. No reliable habituation occurred in either WT or Mecp
levated plus maze (E) was  not affected by transgene knockout. *p < 0.05.
.5.1. The PhenoMaster/LabMaster
The PhenoMaster system consisted of 4 test cages (42 cm × 26.5 cm × 15 cm)
ositioned in a metal frame containing regular infrared beams in both X and Z coor-
inates at a distance of 3 cm and at a rate of 100 Hz. These enable the continuous
ecording of exploratory activity over days, weeks or even months [32,33]. Five
eplications were conducted with Mecp2Stop and WT mice always analysed in paral-
el  and randomly assigned to the test cages. Cage lids were ﬁtted with two  weight
ransducers supporting a feeder and a water bottle, respectively, and transmitting
ata of food and water intake through an AD converter to a PC. Similarly, beam
rossings are stored online and the following parameters calculated: (i) daily food
onsumption; (ii) daily water consumption; (iii) total distance moved in the cage
n  hourly bins and separated for day and night time; (iv) ﬁne movements (linger-
ng) are counted as repetitive breaks of the same beam without progression of the
ody forward; (v) progressive movements (ambulation) are recorded as successive
eams are interrupted; and (vi) habituation during the initial 3 h as distance moved
n  10-min intervals.
Habituation was modelled and mathematically ﬁtted using a nonlinear expo-
ential decay. This model can be applied for biological processes assuming the
ate of decay is always proportional to its remainder [34] and has previously been
pplied for learning and physiological processes [35]. Here, it provided the best ﬁt
or  the behaviour of the control group and at the same time highlighted the differ-
nces that occurred in Mecp2Stop mice. The one phase exponential decay followed
he  equation: Y = (Y0 − Plateau)e−kt + Plateau with t representing time of habitua-
ion  from start to attainment of ﬂoor level, and Y0 indexing the total distance
oved for time point 0. Over time, the total distance per time-bin (here 10 min)
ecays to the plateau (baseline activity or ﬂoor level reached at 3 h) with the rate
onstant k and a half life 0.6932/k. Therefore, the rate constant k determines the
peed of decay, or in other words the steepness of the habituation curve to reach
oor level. In controls, this was  achieved after 4 half-life cycles when the ambula-
ory activity deviated by <5% from the theoretical plateau indicating completion of
abituation.
.5.2. The PhenoTyper
Two sets of 16 PhenoTypers, a video-based observation system for long-term
ontinuous scanning of behavioural activity in mice [24,36] via a built-in digital
nfrared sensitive video camera and infrared light sources in a top unit of each cage
ere used. The body-centred recording of the animal (Ethovision 3.1) was sampled
t 12.2 Hz. Data stored online were calculated for the following parameters: (i) total
ocomotion in the arena summarised in hourly bins during experimental days; (ii)
ime spent in the food zone adjacent to the feeder; (iii) time spent in the water
one  in front of the water bottle (see Fig. 4 for food and water zone locations);
iv)  time spent in an outer zone (4.4 cm distance from wall, see Fig. 4) in patrolling
he boundaries of the home cage; and (v) frequency of entries into the patrolling
one.
Data were analysed using Prism 5.0 (GraphPad Software, San Diego, CA, USA) and
actorial two-way repeated measures analysis of variance (ANOVAs) with genotypemice. Fear-signalling visits to the centre of the open ﬁeld (D) or open arms of the
as between and time as within-subject factor; one-way ANOVAs and t-tests using
Bonferroni adjustment were conducted for group comparisons of locomotor activity,
body weight, food intake and water consumption. Alpha was set to 0.05. Only reliable
differences are shown for clarity.
3. Results
3.1. Mecp2Stop mice progressively increased symptom severity
and body weight
Mecp2Stop female mice already displayed very mild symptoms
upon arrival at our animal facility. The symptom score progres-
sively increased from 6 months of age until approximately 10–12
months, when a compound score of 5/6 was  met  and behavioural
testing commenced (grey highlighted area, Fig. 1A). Mecp2Stop mice
presented with symptoms of motor impairments including reduced
spontaneous locomotor activity, abnormal gait, hindlimb clasping
and the presence of mild tremors. The general health and condition
of the mice was  relatively unaffected. By contrast, WT mice never
developed any anomalies in overall mobility, motor coordination
or their general health. Throughout this period, Mecp2Stop mice pre-
sented with heightened body weight compared to WT (Fig. 1B;
F(1,432) = 75.38; p < 0.0001) mimicking a phenotype observed in
Rett patients [27].
3.2. Reduced locomotor activity in the open-ﬁeld, but no anxiety
phenotype in Mecp2Stop mice
When placed in the open-ﬁeld, Mecp2Stop mice moved less than
WT controls throughout the test (F(1,252) = 6.9; p = 0.01)) (Fig. 1C).
Intriguingly, neither genotype showed any habituation during the
10-min recording period. The times spent in the outer/inner zone
of the open-ﬁeld or in closed arms of the elevated plus maze (EPM)
were determined as indices of anxiety-like behaviour. No difference
between genotypes was obtained for the open ﬁeld (Fig. 1D) (both
groups preferred the outer zone) or the EPM (Fig. 1E).
Based on these data, it seems unlikely that reduced exploratory
activity is due to heightened anxiety levels in Mecp2Stop mice
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Fig. 2. Habituation of Mecp2Stop and WT mice to novel home cages recorded by the PhenoMaster. Animals were recorded upon introduction to the novel cage in 10-min
bins  for 3 h (habituation complete in WT mice). Mean ± SEM. (A) Activity proﬁling conﬁrmed higher activity in WT during early phases of habituation (asterisks are for
10–30  min, p < 0.01). (B) High resolution plot of ﬁrst 10 min  in novel cage. Again, Mecp2Stop mice show lower ambulations relative to WT (compare with Fig. 1C). (C) One-phase
exponential decay ﬁtted to model typical WT habituation proﬁle following equation y = (Y0 − plateau)e−kt + plateau (for details, see Section 2). Data represent means ± SEM
and  dotted lines indicate theoretically calculated 95% conﬁdence intervals. As is obvious, Mecp2Stop mice followed a different habituation proﬁle. Consequently maximal
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hat  left bar for each parameter represents data for WT cohort; data are mean with
p  < 0.05; **p  < 0.01.
owever, it may  in part be a result of motoric deﬁcits of the mice.
e thus sought to conﬁrm this by long-term observations of mice
n home-cages. A corollary of motor impairments and an overall
educed exploratory activity in Mecp2Stop mice might be the per-
istence of this phenotype even when animals are fully habituated
o the environment (i.e. home cage). Alternatively, activity differ-
nces may  only occur during periods when active exploration is
he predominant behavioural state of the animal (i.e. during noc-
urnal food seeking and patrolling). Yet another hypothesis would
uggest that anxiety-related lowering of ambulations in Mecp2Stop
ice may  be observed only during the period of acclimatisation
nd may  wane once this has been completed so that no further
henotype remains. These opposing views were addressed next.
.3. Contrasting habitation curves between Mecp2Stop mice and
T  controls
We  placed female mice into novel home cages and recorded
heir behaviour continuously for 7 days. This period was then fur-
her fragmented into phases of particular interest including the ﬁrst
 h after placement (habituation) and days 3–5 for assessment of
ircadian activity post-acclimatisation.
Habituation tested in the PhenoMaster was  different between
enotypes (interaction between genotype and time point:
(17,238) = 3.9; p < 0.0001), especially during early time points fol-
owing release into novel home cages (Fig. 2A, asterisks). However,
oth genotypes presented with a progressive reduction of activ-
ty lasting about 1 h, after which ﬂoor levels were attained and
abituation was completed. In agreement with exploratory activityeen max  and min  activity) are signiﬁcantly different between genotypes (D). Note
onﬁdence interval. Asterisks: p < 0.05. Overall, WT mice showed faster habituation.
recorded in the open ﬁeld, which lasted 10 min, a similar activity
proﬁle was observed by the PhenoMaster during the initial explo-
ration period (Fig. 2B). Ambulatory activity (distance moved) was
reliably lower in Mecp2Stop mice (F(1,162) = 16; p = 0.001 for geno-
type, ns for time). Although exploration differed in Mecp2Stop mice
from controls, this is unlikely due to differences in anxiety levels
(see Fig. 1D and E) and may  rather be due to a lack of arousal or
motoric dysfunction in the mice.
A more detailed understanding was achieved through nonlinear
modelling of the habituation time course. Extraction of indexes fol-
lowing equation 1 revealed differences in all parameters (Fig. 2D,
see asterisks), and the null hypothesis that both habituation curves
follow the same nonlinear ﬁt was rejected (Fig. 2C; F(3,282) = 13;
p < 0.0001). There were reliable differences in the overall activity
level at start of recording (Y0), the half life of the overall decay in
activity (t1/2), the plateau level of lowest overall activity achieved
at about 4 half life cycles, and the overall span of activities between
max  and min  activation (Fig. 2D). Overall, key values were lower in
Mecp2Stop mice underlining the notion of slower habituation and
lower general activity. They further contest reliable impairments
in non-associative learning in Mecp2Stop mice.
3.4. Mecp2Stop mice present with reduced nocturnal ambulatory
activity in the home cageLong-term scans of activity in home cages were performed
to determine abnormalities in motor coordination and circadian
activity. Lack of Mecp2 indeed compromises the sleep-wake cycle
in 80% of patients [37] for example owing to the failure to activate
152 L. Robinson et al. / Behavioural Brain Research 250 (2013) 148– 156
Fig. 3. Home cage activity as recorded by PhenoMaster. Means ± SEM. (A) Circadian activity over a 24-h period (shaded area indicates dark hours, 19:00–07:00). Mecp2Stop
mice were less active during the dark phase with a strong locomotor deﬁcit apparent at 2–6 h of the dark phase. Indeed, nocturnal activity was signiﬁcantly higher in WT
mice  (Bi), but not during light phases (Bii), and was  due to reductions in both ambulatory (Ci) and ﬁne movements (Cii). Automatically monitored food intake was higher in
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fecp2Stop mice on all recording days (Di) and increased cumulative food intake ove
eriod gene expression and clock entrainment in the hypothala-
us [38]. A selective decrease in nocturnal home-cage activity but
ntact circadian rhythms has been observed with Mecp2308 male
ice [18,23,39]. This however, remains unexplored in our Mecp2
odel and we thus placed female mice in home cage observa-
ion systems to determine their activity pattern over several days.
wo observation systems were chosen for their respective advan-
ages in automatic recording of activity, exploration, food/water
ntake (PhenoMaster) or ﬁne-grained analysis of ambulatory pat-
erns (PhenoTyper).
.4.1. Circadian activity recorded by PhenoMaster
The overall activity pattern of each mouse was recorded con-
inuously for 3 consecutive days and data averaged to give a
4 h proﬁle of activity for each genotype (Fig. 3A). A reduction
n activity is particularly obvious in the Mecp2Stop group during
he nocturnal activity period (19:00–07:00 indicated by grey bars)
hile little if any difference occurred during the light period, when
ice predominantly sleep. No overall shift of activity onset was
ecorded suggesting normal circadian activity. Similar to WT  con-
rols, Mecp2Stop mice demonstrated peaks in activity during the
ark hours and strongly diminished activity during the light phase.
eliable effects of time (F(23,414) = 10.86; p < 0.0001) and genotype
F(1,18) = 4.79; p < 0.05) were in line with the notion that Mecp2Stop
ice are less active than WT.  Separating the overall activity into
octurnal versus diurnal periods (Fig. 3Bi,ii) further substantiated
he ambulatory deﬁcit in Mecp2Stop mice as selective for the noc-
urnal period (Fig. 3Bi) (df = 18; T = 2.44; p = 0.03). And it is during
he dark hours that we observed a reduction in both ambulatory
Fig. 3Ci) (t = 2.1; df = 18; p = 0.03) and ﬁne movements (Fig. 3Cii)
t = 2.7; df = 18; p = 0.01) of Mecp2Stop mice.
At the same time, food intake was always greater in the
ecp2Stop cohort (F(1,18) = 13.10; p = 0.002) (Fig. 3Di), but no differ-
nce in terms of water intake (F < 1, data not shown) was  obtained.
nalysis of cumulative food intake over 3 days found that food
ntake did not differ during light hours, but was reliably higher
uring nocturnal activity periods (Fig. 3Dii; F(1,18) = 45; p < 0.0001
or interaction between genotype and circadian phase – light orys was due to nocturnal eating (Dii). *p < 0.05; ***p < 0.001.
dark), during which the majority of food intake occurred. This may
readily explain the heightened body weight in Mecp2 knock-out
mice (Fig. 1B). This increase in time spent feeding may  also account
for the reduced exploratory activity (Fig. 3Bi) of the Mecp2Stop mice.
3.4.2. Circadian activity recorded by PhenoTyper
Veriﬁcation of the data obtained from PhenoMaster was
achieved in another home cage observation system. While activ-
ity in the PhenoMaster is recorded through the breaking of infrared
beams, video camera observed movement of subjects is detected in
PhenoTypers and food/water intake is indexed indirectly by either
weighing of food hopper/water bottle on a day-by-day basis or by
monitoring the time spent in zones adjacent to food and water
troughs [24]. Furthermore, identiﬁcation of the animal is based on
centre of gravity so that alteration in a small number of pixels is
recognised as movement; this way  of activity detection has a higher
resolution of ambulatory activity. The average 24 h activity proﬁle
from 3 consecutive days of PhenoTyper recordings is presented in
Fig. 4A. Mecp2Stop mice displayed normal circadian rhythms with
a mouse-typical elevation of locomotor activity during hours of
darkness and reduced activity during the light phase. However, as
indicated above, Mecp2Stop mice presented with much fewer ambu-
lations during the nocturnal activity period (19:00–07:00, shaded
areas) relative to WT  mice. Main effects of time (F(23,414) = 65.72;
p < 0.0001) and the genotype by time interaction were reliable
(F(23,414) = 4.1; p < 0.0001). The main difference appeared for noc-
turnal locomotor activity (Fig. 4Bi; df = 18; t = 3.08; p = 0.006), but
not for diurnal movements (Fig. 4Bii). In an additional step, we
explored the activity pattern between the two phenotypes. Typ-
ically, animals spend a considerable amount of time patrolling the
edges of their environment while less time is spent in exploring
the centre of an open home cage. WT mice spent signiﬁcantly more
time patrolling the home cage borders (see diagram in Fig. 4) than
Mecp2Stop mice (Fig. 4Ci, t = 2.4, df = 18, p = 0.02). Since Mecp2Stopmice had higher body weights, a 4.4 cm corridor may bias the data
in favour of the slimmer WT  mice. However, Mecp2Stop animals
entered the zone with the same frequency as WT  mice (Fig. 4Cii)
and we failed to ﬁnd a correlation between body weight and time
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Fig. 4. Home cage activity as recorded by PhenoTyper. Means ± SEM. (A) Circadian activity over a 24-h period (shaded area indicates dark hours, 19:00–07:00). Mecp2Stop
mice were less active relative to WT during the dark hours with a strong locomotor deﬁcit apparent at 2–5 h of the dark phase. Nocturnal activity was signiﬁcantly higher in
WT  mice (Bi), but not diurnal locomotion (Bii). Locomotion of WT mice was  concentrated towards the edges of their home cage (patrolling zone: grey shaded area) in which
they  performed more patrolling (Ci), while Mecp2Stop mice spent less time in this zone. This was  not related to lower ambulatory activity since both WT  and Mecp2Stop mice
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ood  intake data from the PhenoMaster (Fig. 3D). *p < 0.05.
n the patrolling zone for either genotype (data not shown). In
eeping with the lower body weights of WT  controls, the averaged
ime spent in the food zone for the three recording days conﬁrmed
eightened feeding behaviour and food intake in the Mecp2Stop
ohort (Fig. 4D; df = 58; t = 2.21; p = 0.03).
. Discussion
Qualitative assessment of Mecp2Stop heterozygous female mice
ver a period of 6 months conﬁrmed ﬁndings from previous studies
1,5] in that Mecp2Stop mice recapitulate onset and progression of
ymptoms associated with Rett syndrome. These include abnormal
ait, reduced spontaneous activity, tremors and hindlimb clasp-
ng.
.1. Altered body weight and feeding behaviour in Mecp2Stop mice
In addition to these symptoms, female Mecp2Stop mutants also
xhibited increased body weight compared to WT throughout the
ourse of the study. We  progressed with examinations at the age of
 months, at which time a signiﬁcant weight difference had already
een established. Tendency for obesity due to hyperphagia has been
idely reported for Mecp2 null [1,16,40], Mecp2308 truncated hypo-
orphic mice with ∼50% reduction in Mecp2 expression [18,28,41],
nd also in conditional Mecp2 knockout mice [13,19]. Abnormal
eight gain was evident with increasing age and most likely due
o heightened fat deposition in all Mecp2 mutant mice [19,28].
urthermore, region-speciﬁc conditional Mecp2 knockout in neu-
ons within either forebrain [13] or hypothalamus [19] caused an
bese phenotype, which coincided with a signiﬁcant reduction in
ecp2 expression in the hypothalamus [28] and is congruent with
 possible role of Mecp2 as a transcriptional activator/repressor
42]. However, overweight has not been a consistent phenotype
or all mouse models and there are reports of Mecp2 null mice with
o difference [15,23,43–46] or even a reduction in body weight
4,5,14,15,22,43]. time spent in food zone (shaded area: in front of food hopper) (D) in keeping with
In our investigations, we nevertheless observed compelling evi-
dence not only for heightened body weight, but also for alterations
in feeding behaviour since Mecp2Stop mice spent more time in
zones associated with the food hopper and they also ingested
more chow than WT  controls. In contrast to previous work which
concentrated on the overall monitoring of food consumption, we
here determined for the ﬁrst time the circumstances during which
enhanced feeding orientated behaviour in Mecp2Stop mice occurs.
It is precisely during nocturnal hours, when food intake is higher
in Mecp2Stop mice and coincident with hypoactivity as recorded
in both PhenoMaster and PhenoTyper home cages. Replicating
the observation in two different recording environments not only
strengthens the quality of the equipment, but also underlines the
robustness of the phenotype. It further supports the notion that
circadian activity remained normal in our Mecp2Stop mice and
the genotype speciﬁcally affected food consumption at periods of
heightened ambulatory activity and metabolic requirements. Likely
mediators of this effect are hypothalamic Sim1-expressing neu-
rones, which when selectively depleted of Mecp2 also caused a
hyperphagic phenotype. A possible explanation for this phenotype
is either the deregulation of the melanocortin pathway [19] or a rise
in leptin levels, which has been observed in Rett patients [47] and
is similarly found in obese children and adults [48]. The absence
of Mecp2 in the hypothalamus could therefore explain the hyper-
phagic and obesity-like phenotype of our female Mecp2Stop mice,
but requires further conﬁrmatory studies.
Any discrepancies between the different mouse models may  be
explained by genetic modiﬁers. Towards this end, Guy and col-
leagues [5] observed changes in body weight in Mecp2 null mice
dependent on their genetic background. This was conﬁrmed by
Samaco et al. both with hypomorphic Mecp2 mice [41] and more
recently Mecp2+/− female [16] cohorts backcrossed on to C57Bl/6
or FVB backgrounds. A factor superimposed here is age and gen-
der, which widely differed between studies. Most reported work on
weight reductions concentrated on young male Mecp2 mice ∼4–7
weeks of age [5,14,15,22] for which increased body weight was
observed from ∼7 weeks of age onwards [15,19,28,40,41]. Here, we
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eport hyperphagia/increased body weight in heterozygous female
ecp2 mutant mice which is in agreement with studies of Mecp2+/−
emales [1,16] and obesity in some Rett Syndrome patients [27]. By
ontrast, other studies have reported no effect on body weight of
ecp2+/− female mice [44–46].
.2. Reduced locomotion in Mecp2Stop mice may  be due to deﬁcits
n information/motivational processing
Locomotor activity of Mecp2Stop female mice in the open-
eld was considerably lower compared to WT,  consistent with
revious reports of decreased locomotor activity in the same appa-
atus [5,6,13,15,16,49]. This locomotor impairment is in agreement
ith previous studies from female Mecp2+/− mice that have con-
istently reported deﬁcits in motor function [5,15,16,44,50,51].
owever, some experimenters have failed to determine this
henotype for Mecp2308 mice [18,52], hypomorphic mice [28], con-
itional deletion of Mecp2 from hypothalamus [19] and Mecp2 null
ice [14,15,53]. Gemelli et al. [13] used forebrain-speciﬁc dele-
ion of Mecp2 and reported an initial reduction in activity in a
ovel environment lasting for 5 min, before activity levels nor-
alised and remained similar to WT  for the habituation period
f 2 h. This effect was ampliﬁed in our Mecp2Stop mutants last-
ng for at least 10 min  during open-ﬁeld exposure (Fig. 1) or
p to 30 min  during habituation to a novel home cage (Fig. 2).
hat is different in our model is that the resulting habitua-
ion curve diverged between genotypes. Although habituation
f both WT  and Mecp2Stop mice followed a non-linear ﬁt, there
ere considerable differences pertaining not only to the half-life
f activity decay, but also the plateau and peak activity levels,
hat were higher for WT  mice. These data strongly suggest dys-
unctional information/motivational processing in Mecp2Stop when
xploring novel environments, since putative anomalies in anxiety-
elated behaviour both in open ﬁeld and elevated plus maze
ere excluded (for similar results on other Mecp2 models, see
5,14,15,22,28,41,43,52,53]). It contrasts to studies that reported
ither reduced or elevated anxiety levels in open ﬁeld, elevated
lus maze, zero maze or light/dark box following altered expres-
ion of Mecp2 either in speciﬁc brain regions [13,17,19] or globally
6,16–18,20–23,50,52], previous ﬁndings with female Mecp2 +/−
ice have observed either a reduction in anxiety [16] or no effect
15]. Studies with mouse models have suggested that the presence
f anxiety-like behaviours is dependent on the mutation [54] even
hough anxiety is a characteristic feature in Rett patients [55,56].
Overall exploratory activity is a predictor of general cognitive
bility ‘g’ in mice [57] and humans [58]. Differences in exploration
re most predictive during early periods of exposure to a novel envi-
onment (open ﬁeld, novel cage), but diminish at later stages when
symptotic activity levels are attained. Such a time course follows
 one-phase exponential decay function for which we  secured a
eliable difference between WT  and Mecp2Stop mice for Y0, i.e. the
aximal locomotor activity at test start. This difference was  stri-
ingly similar to the segregation found in the open ﬁeld underlining
he robustness of this observation and implicating Y0 as a critical
ndex for learning capability. This assertion is further strengthened
y the observation that non-associative habituation to a novel envi-
onment upon ﬁrst exposure to PhenoMaster or PhenoTyper cages
ollows different time courses and could be modulated and thus
eﬂect general learning abilities (since in itself it is a form of learn-
ng). A mouse with high ‘g’ would more readily acquire information
bout the environment thereby quickly reducing activity (calcu-
ated as half life of activity) and meeting asymptotic plateau faster
han mice with lower learning ability. Both habituation rate and
lateau were signiﬁcantly different between genotypes suppor-
ing the contention that the rate of information processing whichResearch 250 (2013) 148– 156
is purported by the working memory system and is likely to be
compromised in Mecp2Stop mice.
Such a shunting of information/motivational processing was
further conﬁrmed for the female Mecp2Stop cohort during long-
term recording of circadian activity in home cages (PhenoMaster
and PhenoTyper). While there was no evidence for any circadian
anomaly, it became clear that the trigger of activity i.e. change
from light to dark phase induced a much lower activation in
terms of lingering and ambulation in Mecp2Stop relative to WT.
This reduction in nocturnal activity but unaffected circadian activ-
ity with Mecp2Stop females corroborates work with male Mecp2308
mice [18,23,39]. Aberrant motivation has been used to account
for frequently observed variability in intellectual and developmen-
tal disabilities, including autism and Rett syndrome. Towards this
end, a novel environment, or changes in contexts that are oth-
erwise austere or barren constitutes an environmental challenge
and induces motivational operations to seek automatic positive
reinforcement [59]. These motivational operations, however, often
require attention-maintained behaviour, which seems to be fail-
ing in our model possibly due to frontal lobe dysinhibition [60,61].
While unconﬁrmed to date for our mice, the global knockdown of
Mecp2 may  also compromise functions mediated by the prefrontal
cortex; indeed, 100% of Rett patients analysed for frontal cortex
expression presented with diminished Mecp2 [62]. Thus lowered
attention span in Mecp2Stop mice may  account for the brief activity
peak observed at the beginning of the dark phase, which is then
followed by a trough at a period when WT  mice maintain a high
level of locomotor and exploratory activity. A more ﬁne-grained
dissection of the recorded activity, however, suggested a reduc-
tion of ﬁne movements, such as head shakes, grooming, or rearings
in the knock-out line, with ambulatory progressions also affected
(Fig. 3Ci and Cii).
Reduced locomotor activity may  also be explained by altered
sleep patterns, and these are widely manifest in Rett patients
[37,63]. Especially the emergence of repeated daytime napping
and its progression could have affected overall activity observed
during nocturnal activity peaks and thereby have caused a low-
ering of locomotor activity as seen in Mecp2Stop mice. Although
both monitoring systems obtained continuous recordings from all
subjects, neither can discriminate sleep phases from wake quies-
cence. Resolution of this issue thus would require detailed vigilance
staging of animals based on global electro-encephalograms (EEGs).
However, while detailed determination of sleep signatures requires
further experimental work, these would offer unlikely explanations
for differences in habituation (Y0, decay and asymptotic plateau),
which were observed during periods of active wakefulness not
interrupted by short naps.
4.3. Conclusions
Behavioural assessment of Mecp2Stop heterozygous female mice
to determine motor and anxiety phenotypes revealed overall
reductions in locomotor activity but no effect on anxiety levels or
circadian rhythms with reduced activity observed during the dark
but not light cycle. In addition to the motor phenotype mice also
presented with hyperphagia/increased body weight. As discussed
in detail these ﬁndings both corroborate and contrast with stud-
ies of other mice with altered Mecp2 levels. Following on from the
present results further work is needed to determine if the disrup-
tion in habituation to the novel home cage environment observed
in this study are indeed linked to deﬁcits in cognitive processing
of the mice and it would also be beneﬁcial to use EEG to explain
potential differences in the sleep/wake composition of these mice
during the nocturnal phase of testing when they are consistently
less active.
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